Jim Cramer's Mad Money Lightning Round Picks, 7/24/07

Miriam Metzinger submits: Stocks discussed in the lightning round session of Jim Cramer’s Mad Money TV program, Tuesday July 24. Click on a stock ticker for more analysis:

Bullish calls:

CV Therapeutics (CVTX): 'Small-molecule biotech company, dedicated to solving one of the most pressing problems in the world, which is all the cardiology problems which can be solved, and I think that that is precisely the kind of stock to buy in this environment.'
Nastech Pharmaceutical (NSTK): 'Biotech's coming back. With a worldwide slowdown figured in...that's a winner!'
Celgene (CELG)
Discovery (DISCA): 'Can you imagine a whole network with good programming that people tune in... that isn't about being stupid or lazy, or making people look awful, and humiliating them with reality shows?... How can it be?... Actually, I think it's really well-run. I think it goes higher. I think it could go to $27, so I would stay long, and maybe pull the trigger at $24.'
Apple (APPL): ' ... I would start adding... I do think that AAPL has come down enough to start rebuilding it, but not aggressively, because I need to see the quarter...'

Bearish calls:

MasterCard (MA): 'Let MA come in, before we pull the trigger... Don't buy, don't buy. It's just a little too expensive for me right now...'
Trump Entertainment Resorts (TRMP): 'They could not sell themselves, so I don't even know what it's worth anymore... I've got to tell you, this is a distinctly bear market stock. I don't want to touch it... Management turnover... it's not for me...'
Navteq (NVT): 'We sell, sell, sell... we take off the gain, and we live to play again.'

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and Wall Street Confidential Picks.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with CNBC, Jim Cramer or TheStreet.com

Comments

[jimmy Turano:]

July 27th,
Now that the market dropped over 300 points yesterday, Do you think Cramer is officially done TOUTING "NSTK?
I think so, after all in 12 days the rotten earnings report comes out.
And the stock price should rightfully test new lows like I've said for the past
3 weeks. This is one stock shareholders love to suffer with!

2007 Jul 27 09:16 AM

[jimmy Turano:]

July 28th, saturday
The market goes down again, and low and behold Cramer Touts 'nstk' again for the 17 time.
Success and Power sometimes leads to ones downfall. And in the case of 'nstk', their past record literally stinks.
Their earnings stink and growth,return on equity, and managements effectiveness is sub par but most important
they're past record with Fda and big Pharma's are disappointing to say the least.
But there Cramer stands on his soap box touting the death out of Nastech.
Why? There are companies far advanced in autism, obesity, and RNAI period than 'nstk'.
Shareholders who bought nstk 11 years ago at $20 dollars are still in the Red!
Shareholders who bought last year at $19 are still in the Red!
After 24 years Jim Cramer are you telling shareholders that this is a fairy tale story in the making?
A complete turnaround for nstk?
A 360 and Fda approvals without any hitches like Big Pharma's get all the time?
Your success & power has gone to your head unless there is something not disclosed, but that would be illegal, right JIM?

2007 Jul 28 09:42 AM